Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-17-000525
Filing Date
2017-01-27
Accepted
2017-01-27 16:57:50
Documents
2
Period of Report
2017-01-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_148555425406229.html 3  
1 FORM 3 wf-form3_148555425406229.xml 3 1653
2 MCCOURT POA ex-24.htm EX-24 3687
  Complete submission text file 0001628280-17-000525.txt   6712
Mailing Address 101 HUDSON STREET SUITE 3610 JERSEY CITY NJ 07302-6548
Business Address 101 HUDSON STREET SUITE 3610 JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Issuer) CIK: 0001178253 (see all company filings)

EIN.: 562181648 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MEDIVATION, INC. 525 MARKET ST., 36TH FLOOR SAN FRANCISCO CA 94105
Business Address
McCourt Marion (Reporting) CIK: 0001663758 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36365 | Film No.: 17554465